Outcomes researcher moves south to national nonprofit

Share this article:
Dave Davis, MD, the University of Toronto academic widely respected for his research on outcomes-oriented education, will join the Washington, DC-based Association of American Medical Colleges.

Davis will assume a new position for this nonprofit association—VP, continuing health
education and physician performance improvement in the division of med ed. AAMC oversees several initiatives aimed at improving med ed.

Davis, who currently leads the University of Toronto CME program, said he will work to up awareness of CME, its effectiveness and linkages to the health system. “To have an opportunity at the end of my career to spend time with colleagues who I value in CME across the nation is just a wonderful opportunity,” Davis told MM&M.

The announcement follows part of a sabbatical year Davis spent at AAMC.

ACCME’s updated compliance criteria also prompted the move. “It made me think some of these goals might be attained,” Davis said.

Davis’ current duties have included overseeing a knowledge translation program endowed by Li Ka Shing at Toronto’s St. Michael’s Hospital. He earlier created a CE division at Canada’s McMaster University. Davis said that, in some medical schools, QI in patient care and CME are not meshed well. “Clearly we need to bring those two dimensions together.”

He will begin his new post in late summer or fall as soon as he winds down his medical practice.
Davis will report to Carol Aschenbrener, MD, AAMC EVP.

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...